Posted by Michael Wonder on 01 Dec 2022
Afraid of pharma pushback, a health data broker puts up a barrier to drug pricing information
1 December 2022 - At a time when many Americans are clamouring for more transparency into prescription drug pricing, one key provider of that data is making it harder to access the information.
A new venture called Merative - which was formed recently from the ashes of IBM's Watson health division - has decided it will nom longer provide the media with pricing changes for specific medicines.
